Abivax SA (ABVX)
NASDAQ: ABVX · IEX Real-Time Price · USD
13.95
-0.14 (-0.99%)
May 13, 2024, 4:30 PM EDT - Market closed
Abivax Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Abivax stock have an average target of 32, with a low estimate of 16 and a high estimate of 50. The average target predicts an increase of 129.39% from the current stock price of 13.95.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Abivax stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +258.42% | Apr 29, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $42 | Buy | Initiates | $42 | +201.08% | Apr 29, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | +14.70% | Apr 11, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $20 | Buy | Initiates | $20 | +43.37% | Nov 14, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $15 | Hold | Initiates | $15 | +7.53% | Nov 14, 2023 |
Financial Forecast
Revenue This Year
952.48K
from 4.62M
Decreased by -79.39%
Revenue Next Year
62.17M
from 952.48K
Increased by 6,427.41%
EPS This Year
-2.27
from -3.43
EPS Next Year
0.48
from -2.27
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.9M | 315.0M | n/a | 395.1M | 1.4B |
| Avg | 952,476 | 62.2M | n/a | 155.5M | 555.2M |
| Low | n/a | n/a | n/a | 59.5M | 170.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 6.1% | 32,971.7% | - | - | 818.7% |
| Avg | -79.4% | 6,427.4% | - | - | 257.0% |
| Low | - | - | - | - | 9.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.99 | 6.58 | -2.24 |
| Avg | -2.27 | 0.48 | -2.17 |
| Low | -2.50 | -2.50 | -2.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.